abstract |
The present invention relates to the provision of a novel immunogen comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for preventing, treating or alleviating PCSK9-mediated disorders. The invention further relates to these agents, immunogenic compositions, and methods for producing the pharmaceutical compositions, and their use in pharmaceuticals. |